Patritumab Deruxtecan

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Patritumab Deruxtecan
Treatment and conditionWhere it standsTrials
Patritumab Deruxtecan for endometrial neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Patritumab Deruxtecan for neoplasm metastasisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
Patritumab Deruxtecan for prostatic neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Patritumab Deruxtecan for uterine cervical neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1